Decision Making in Big Pharma vs. Small Pharma

On many occasions, I have the opportunity to speak with leaders at small pharmaceutical and biotech companies. They always say, “We don’t operate like big pharma” or “I’m not interested in hearing the best practices from big pharma.” As a younger and less experienced leader from big pharma, I couldn’t fathom what they meant by[…]

The Merck-Quintiles Partnership: Sponsor, Do You Take This CRO….?

Recently, Merck Serono entered into a new, five-year clinical development deal. The deal was with none other than Quintiles, the world’s largest CRO (with approximately $3.7 billion in revenue). Moving forward, Quintiles will be the sole primary provider of Merck Serono’s outsourced clinical development services for its global clinical programs. The agreement will span the[…]